Eli Lilly, Novo Nordisk Shares Fall as Weight-Loss Drug Competition Ramps Up
Shares of drugmakers Eli Lilly and Novo Nordisk continued sinking Thursday on concerns their dominance of the booming anti-obesity drug market is under threat. Shares of Eli Lilly have fallen about 10% over the last two days,
Shares of weight loss drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) extended a multi-day decline on Thursday, losing ...
Stock splits can sometimes be an effective way for a company to generate excitement around its stock. It's a sign that the ...
24/7 Wall St on MSN59m
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 553% and ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's ...
We believe that Eli Lilly stock (NYSE: LLY) is currently a better pick than its industry peer – Pfizer stock , given its ...
Eli Lilly and Company stock is moving lower on Thursday on possible continued weakness after recent weight loss data from ...
Morgan Stanley analysts are setting a bullish tone for the upcoming earnings season, with specific companies expected to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback